Žirmūnų psichikos sveikatos centras

Micronutrients Show Benefit for Children With ADHD and Emotional Dysregulation

Žirmūnų psichikos sveikatos centro naujienos

Children with ADHD and emotional regulation disorders who consumed a micronutrient formal made of essential minerals and vitamins were three times more likely to show improvements in symptoms compared to those who did not consume the formula.

A study in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP) reports children with ADHD and emotional regulation randomized to take a micronutrient formula were three times more likely to show symptomatic improvement on blinded clinician ratings, compared to those in the placebo group (54% versus 18%).

The micronutrient formula, consisting of all known vitamins and essential minerals, was administered for eight weeks.

“Supplementing with all known vitamins and essential minerals, at doses between Recommended Daily Allowance and Upper Tolerable Limit, may improve mood and concentration in children with ADHD and emotional dysregulation,” said lead author Jeanette Johnstone, PhD, Assistant Professor, Department of Child and Adolescent Psychiatry, Oregon Health & Science University and Helfgott Research Institute, National University of Natural Medicine.

“These findings, replicating results of a previous randomized trial of micronutrients in children with ADHD conducted in New Zealand, confirm that supplementation with a broad range of nutrients may benefit some children. These findings may offer guidance to doctors and families seeking integrative treatments for their children with ADHD and related emotional dysregulation,” Dr. Johnstone noted.

The triple-blinded study enrolled 135 medication-free children and their parents at three sites (Portland, Oregon; Columbus, Ohio; Alberta, Canada) and randomized participants to either micronutrient or placebo capsules for eight weeks. Three-quarters of the participants were adherent to the study protocol.

The intervention was well-tolerated, with no significant differences in adverse events between the micronutrient and placebo groups, or safety concerns based on blood and urine tests.

Parents, children and clinicians were blinded to treatment allocation and were not able to guess assignment better than chance.

In addition to behavioral and emotional benefits, children taking micronutrients grew 6mm more in height than those taking placebo after adjusting for baseline height.

“The growth finding, also a replication from the previous child micronutrient study, is particularly encouraging, as height suppression is a concern with first-line ADHD medication,” Dr. Johnstone added.

In contrast to clinician ratings, parents, who were also blinded to their child’s treatment allocation, reported significantly improved behavior that was equal in both the micronutrient and placebo groups, with no significant between-group differences, highlighting the importance of blinded clinician ratings.


https://neurosciencenews.com/micronutrients-adhd-20472/

Google Translate
Mediacijos paslaugos
SKIRTINGOS SPALVOS 10 LAIDA - Justės Arlauskaitės-Jazzu istorija (savižudybių prevencija)

SKIRTINGOS SPALVOS 10 LAIDA - Justės Arlauskaitės-Jazzu istorija (savižudybių prevencija)

16 birž., 2023
Socialinė iniciatyva Skirtingos Spalvos pristato dešimtąją laidą ir jos pašnekovę – Justę Arlauskaitę-Jazzu. Šioje laidoje žinoma atlikėja kalbėjo apie emocinę sveikatą ir savižudybių prevenciją Itin atvirame pokalbyje Justė pasidalijo įvairiomis gyvenimo patirtimis apie santykius su žmonėmis, vaikystėje išmoktas pamokas, ilgai trukusią kovą su priklausomybėmis, panikos atakomis, kelionę sveikimo link ir iš naujo užgimusią Justę, kuomet ant rankų pradėjo sūpuoti savo sūnų Majų. Kaip ir pati Justė laidos metu atviravo, kad gyvenime atlikėja save suprato kaip balsą, o kai jį staiga prarado, nebematė tikslo toliau gyventi, jautėsi nereikalinga nei sau, nei kitiems. Užtruko laiko save susirinkti ir suprasti, kad Justė nėra tik apie balsą. „Pradėjau remtis į kitus žmones, ieškoti pagalbos, kurios nėra gėda ieškoti, tai yra drąsa prašyti pagalbos ir eiti šviesos link“, – atvirauja Justė.
EPA 2023

EPA 2023

05 bal., 2023
Kovo 25-28 dienomis Paryžiuje vyko 31- asis Europos psichiatrų kongresas, kuriame dalyvavo du gydytojai psichiatrai iš mūsų centro. Daug naujų tyrimų, gydymo metodų. Kiekvieną dieną buvo skaitoma po 2 pranešimus apie ADHD. Europoje šiam sutrikimui pastaruoju metu skiriamas didelis dėmesys.

Study finds anti-depressants actually change the structure of the brain

27 vas., 2023
Scientists have made a startling discovery. According to a new study researchers presented at the 35th Annual European College of Neuropsychopharmacology in Vienna, certain anti-depressants can cause drastic changes in the brain. In fact, they may even be able to rewire brains affected by major depressive disorder. Major depressive disorder, or MDD as I’ll refer to it from here out, is a mental health disorder that is characterized by persistent depressing moods, dark thoughts, and a general loss of interest in any activities. It can cause major impairment in the daily lives of people affected by it. Now, though, we may be able to treat it by using certain anti-depressants to change how the brain is wired. In the past, researchers have found that anti-depressants and even behavioral therapy and electroconvulsive therapy just don’t work for everyone that suffers from MDD. However, a group of researchers in Germany are now claiming that anti-depressants can change the brain structures themselves. However, they aren’t sure how long those changes will remain. Past studies have found that serious bouts of depression are often associated with a change in the volume of gray matter and white matter found within the brain. Each type of brain matter is associated with different functions of the body, and any changes in them can drastically change how our brains react. As such, being able to change the brain’s structure with anti-depressants is huge.
Share by: